Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
Príomhchruthaitheoirí: | Yip, B, Pellagatti, A, Vuppusetty, C, Giagounidis, A, Germing, U, Lamikanra, A, Roberts, D, Fernandez-Mercado, M, McDonald, E, Killick, S, Wainscoat, J, Boultwood, J |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2012
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Effects of L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
de réir: Yip, B, et al.
Foilsithe / Cruthaithe: (2012) -
Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
de réir: Yip, B, et al.
Foilsithe / Cruthaithe: (2013) -
Activation of the mTOR signaling pathway by L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
de réir: Yip, B, et al.
Foilsithe / Cruthaithe: (2013) -
Activation of the mTOR Signaling Pathway by L-Leucine in RPS14-Deficient Erythroid Cells
de réir: Yip, B, et al.
Foilsithe / Cruthaithe: (2012) -
L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients
de réir: Bello, E, et al.
Foilsithe / Cruthaithe: (2018)